Semaglutide, lipid-lowering drugs, and NAFLD.

N. Katsiki,V. Athyros,A. Karagiannis,D. Mikhailidis
DOI: https://doi.org/10.1016/S2213-8587(17)30109-2
2017-05-01
The Lancet Diabetes and Endocrinology
Abstract:
What problem does this paper attempt to address?